Patent ID: 7807165

Claim:
A method for treating a disease characterized by aberrant deposition of β-amyloid in a subject, comprising administering to the subject an effective amount of an antibody that specifically binds to a β-amyloid peptide or an aggregated form of a β-amyloid peptide(Aβ), wherein the antibody comprises a heavy chain variable region comprising: (a) a CDR1 comprising the amino acid sequence of SEQ ID NO:3; (b) a CDR2 comprising the amino acid sequence of SEQ ID NO:4; and (c) a CDR3 comprising the amino acid sequence of SEQ ID NO:5; and a light chain variable region comprising: (d) a CDR1 comprising the amino acid sequence of SEQ ID NO:6; (e) a CDR2 comprising the amino acid sequence of SEQ ID NO:7; and (f) a CDR3 comprising the amino acid sequence of SEQ ID NO:8.